Revised MRPs of 1,364 anti-cancer drugs take effect, saving consumers ₹3,540 crore a year
FROM THE WIRE · THEHINDUBUSINESSLINE.COM
Revised MRPs cut 1,364 anti-cancer drugs, saving ₹3,540 cr/year, with 679 brands slashed by over 50% and transparent pricing enforced nationwide.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralThe revision of maximum retail prices is a regulatory decision with effects on the Indian pharmaceutical sector.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01The new MRPs cover 1,364 anti-cancer formulations.
- 02Estimated savings for consumers are ₹3,540 crore per year.
- 03679 brands are cut by more than 50%.
- 04Transparent pricing is enforced nationwide.